NDC 80425-0237-01 - Diclofenac Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0237
- Requested NDC
- 80425-0237-01
- Package NDCs from labels
- 80425-0237-1, 80425-0237-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diclofenac Sodium - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0237-1 | Diclofenac Sodium | 150 mL in 1 BOTTLE | SOLUTION | 150 | 4 | |
| 80425-0237-1 | Diclofenac Sodium | 1 in 1 CARTON | SOLUTION | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0237 | DICLOFENAC SODIUM SOLUTION [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 4 | Current NDC, 2 package rows | 20250102_f1896c84-b18a-d49d-e053-2995a90aaab3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0237-1 | ML - Milliliter | 80425-0237 | e028fbd8-98bc-4f4a-97fa-fd08d74407b3 | 1 | 2023-03-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac Sodium 1.5% | DICLOFENAC SODIUM TOPICAL | SOLA Pharmaceuticals | c3f33952-44a8-71b2-e053-2a95a90abda2 | 2025-12-08 | Boxed warning, Warnings, Adverse reactions | 857700 QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Advanced Rx of Tennessee, LLC | 4539e9e7-5d82-3b36-e063-6394a90a1396 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Aleve Arthritis Pain Gel | DICLOFENAC SODIUM | Bayer HealthCare LLC | bad675d1-1204-0136-e053-2995a90a994e | 2025-12-04 | Warnings | QTG126297Q |
| Xiclofen | DICLOFENAC SODIUM, METHYL SALICYLATE | ASCLEMED USA INC. | 263f64d5-da3e-43cc-a651-2136f3b1f2ea | 2025-12-02 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM TOPICAL | Proficient Rx LP | 140a2c64-4996-4da3-b10f-1b8235ebde9d | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM TOPICAL | Alembic Pharmaceuticals Inc. | 30c3c3c5-b4f3-4321-ae25-b2c588ad0551 | 2025-11-28 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Aurobindo Pharma Limited | e5c0863a-edb7-4f46-a396-c9b2d8785cf8 | 2025-11-19 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | SOLA Pharmaceuticals, LLC | b8072af2-9940-4827-9fbd-de46ad8bf929 | 2025-11-17 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium 1.5% | DICLOFENAC SODIUM TOPICAL | PHOENIX RX LLC | 3b40a448-3f5e-fe6f-e063-6394a90a32df | 2025-11-17 | Boxed warning, Warnings, Adverse reactions | 857700 QTG126297Q |
| ARTHRITIS PAIN RELIEVER | DICLOFENAC SODIUM | H E B | 027803c5-85ae-4b86-8bd4-e61f8f34d036 | 2025-11-17 | Warnings | QTG126297Q |
| ARTHRITIS PAIN RELIEVING | DICLOFENAC SODIUM | Meijer, Inc. | 5cc570c6-2585-4d1a-9352-b1161458af9a | 2025-11-17 | Warnings | QTG126297Q |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM | PHOENIX RX LLC | 41472cca-278b-934b-e063-6294a90aaf5d | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | PHOENIX RX LLC | 4382cc15-8978-4f3b-e063-6394a90a9ecb | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium Topical 1% | DICLOFENAC SODIUM | YYBA CORP | 043df5d2-6f3e-311f-e063-6294a90a23d7 | 2025-11-10 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Advanced Rx of Tennessee, LLC | 0b4fd47f-903c-097b-e063-6394a90a49ab | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | ANDA206116 857700 QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Lupin Pharmaceuticals, Inc. | 609c5344-9c97-4fa8-ad53-d0f622ce64ec | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Dr. Reddy's Laboratories Inc. | c88b2512-0255-658d-252a-c006275159b0 | 2025-10-28 | Warnings | QTG126297Q |
| Arthritis Pain | DICLOFENAC SODIUM TOPICAL GEL, 1% | Strategic Sourcing Services, LLC | 5de514ee-fd59-ef95-8dc3-16e34321572b | 2025-10-28 | Warnings | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Chain Drug Marketing Association INC | 625d21e8-0731-1157-30fe-9f9868ff8dc4 | 2025-10-28 | Warnings | QTG126297Q |
| Diclofenac Sodium Topical Gel 1% | DICLOFENAC SODIUM TOPICAL GEL, 1% | Walgreens Company | 40d0553b-a97a-1315-3fca-8ef38611505e | 2025-10-28 | Warnings | QTG126297Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.